NARRMDA:用于mirna -疾病关联预测的负面感知和基于评级的推荐算法

IF 3.743 Q2 Biochemistry, Genetics and Molecular Biology
Lihong Peng, Yeqing Chen, Ning Ma and Xing Chen
{"title":"NARRMDA:用于mirna -疾病关联预测的负面感知和基于评级的推荐算法","authors":"Lihong Peng, Yeqing Chen, Ning Ma and Xing Chen","doi":"10.1039/C7MB00499K","DOIUrl":null,"url":null,"abstract":"<p >An increasing amount of evidence indicates that microRNAs (miRNAs) are closely related to many important biological processes and play a significant role in various human diseases. More and more researchers have begun to seek effective methods to predict potential miRNA–disease associations. However, reliable computational methods to predict potential disease-related miRNAs are lacking. In this study, we developed a new miRNA–disease association prediction model called Negative-Aware and rating-based Recommendation algorithm for miRNA–Disease Association prediction (NARRMDA) based on the known miRNA–disease associations in the HMDD database, miRNA functional similarity, disease semantic similarity and Gaussian interaction profile kernel similarity. NARRMDA combined a rating-based recommendation algorithm and a negative-aware algorithm to score and rank miRNAs without known associations with investigated diseases. Furthermore, we used leave-one-out cross validation to evaluate the accuracy of NARRMDA and compared NARRMDA with four previous classical prediction models (RLSMDA, HDMP, RWRMDA and MCMDA). As it turned out, NARRMDA and the other four prediction models achieved AUCs of 0.8053, 0.6953, 0.7702, 0.7891 and 0.7718, respectively, which proved that NARRMDA has superior performance of prediction accuracy. Furthermore, we verified the prediction results associated with colon neoplasms, esophageal neoplasms, lymphoma and breast neoplasms by two different validation schemas. In these case studies, 92%, 84%, 92%, and 100% of the top 50 potential miRNAs for these four diseases were confirmed by experimental discoveries, respectively. These results further show that NARRMDA has reliable performance of prediction ability.</p>","PeriodicalId":90,"journal":{"name":"Molecular BioSystems","volume":" 12","pages":" 2650-2659"},"PeriodicalIF":3.7430,"publicationDate":"2017-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1039/C7MB00499K","citationCount":"20","resultStr":"{\"title\":\"NARRMDA: negative-aware and rating-based recommendation algorithm for miRNA–disease association prediction†\",\"authors\":\"Lihong Peng, Yeqing Chen, Ning Ma and Xing Chen\",\"doi\":\"10.1039/C7MB00499K\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >An increasing amount of evidence indicates that microRNAs (miRNAs) are closely related to many important biological processes and play a significant role in various human diseases. More and more researchers have begun to seek effective methods to predict potential miRNA–disease associations. However, reliable computational methods to predict potential disease-related miRNAs are lacking. In this study, we developed a new miRNA–disease association prediction model called Negative-Aware and rating-based Recommendation algorithm for miRNA–Disease Association prediction (NARRMDA) based on the known miRNA–disease associations in the HMDD database, miRNA functional similarity, disease semantic similarity and Gaussian interaction profile kernel similarity. NARRMDA combined a rating-based recommendation algorithm and a negative-aware algorithm to score and rank miRNAs without known associations with investigated diseases. Furthermore, we used leave-one-out cross validation to evaluate the accuracy of NARRMDA and compared NARRMDA with four previous classical prediction models (RLSMDA, HDMP, RWRMDA and MCMDA). As it turned out, NARRMDA and the other four prediction models achieved AUCs of 0.8053, 0.6953, 0.7702, 0.7891 and 0.7718, respectively, which proved that NARRMDA has superior performance of prediction accuracy. Furthermore, we verified the prediction results associated with colon neoplasms, esophageal neoplasms, lymphoma and breast neoplasms by two different validation schemas. In these case studies, 92%, 84%, 92%, and 100% of the top 50 potential miRNAs for these four diseases were confirmed by experimental discoveries, respectively. These results further show that NARRMDA has reliable performance of prediction ability.</p>\",\"PeriodicalId\":90,\"journal\":{\"name\":\"Molecular BioSystems\",\"volume\":\" 12\",\"pages\":\" 2650-2659\"},\"PeriodicalIF\":3.7430,\"publicationDate\":\"2017-10-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1039/C7MB00499K\",\"citationCount\":\"20\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular BioSystems\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://pubs.rsc.org/en/content/articlelanding/2017/mb/c7mb00499k\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular BioSystems","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2017/mb/c7mb00499k","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 20

摘要

越来越多的证据表明,microRNAs (miRNAs)与许多重要的生物学过程密切相关,并在各种人类疾病中发挥重要作用。越来越多的研究人员开始寻求有效的方法来预测潜在的mirna与疾病的关联。然而,目前还缺乏可靠的计算方法来预测潜在的疾病相关mirna。在本研究中,我们基于HMDD数据库中已知的miRNA -疾病关联、miRNA功能相似度、疾病语义相似度和高斯相互作用谱核相似度,开发了一种新的miRNA -疾病关联预测模型,称为基于负面感知和评级的miRNA -疾病关联预测推荐算法(NARRMDA)。NARRMDA结合了基于评级的推荐算法和负面感知算法,对与所研究疾病没有已知关联的mirna进行评分和排名。此外,我们使用留一交叉验证来评估NARRMDA的准确性,并将NARRMDA与先前的四种经典预测模型(RLSMDA、HDMP、RWRMDA和MCMDA)进行比较。结果表明,NARRMDA与其他四种预测模型的auc分别为0.8053、0.6953、0.7702、0.7891和0.7718,证明NARRMDA具有较好的预测精度性能。此外,我们通过两种不同的验证方案验证了结肠肿瘤、食管肿瘤、淋巴瘤和乳腺肿瘤的预测结果。在这些案例研究中,这四种疾病的前50种潜在mirna分别有92%、84%、92%和100%得到了实验发现的证实。这些结果进一步表明,NARRMDA具有可靠的预测能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

NARRMDA: negative-aware and rating-based recommendation algorithm for miRNA–disease association prediction†

NARRMDA: negative-aware and rating-based recommendation algorithm for miRNA–disease association prediction†

An increasing amount of evidence indicates that microRNAs (miRNAs) are closely related to many important biological processes and play a significant role in various human diseases. More and more researchers have begun to seek effective methods to predict potential miRNA–disease associations. However, reliable computational methods to predict potential disease-related miRNAs are lacking. In this study, we developed a new miRNA–disease association prediction model called Negative-Aware and rating-based Recommendation algorithm for miRNA–Disease Association prediction (NARRMDA) based on the known miRNA–disease associations in the HMDD database, miRNA functional similarity, disease semantic similarity and Gaussian interaction profile kernel similarity. NARRMDA combined a rating-based recommendation algorithm and a negative-aware algorithm to score and rank miRNAs without known associations with investigated diseases. Furthermore, we used leave-one-out cross validation to evaluate the accuracy of NARRMDA and compared NARRMDA with four previous classical prediction models (RLSMDA, HDMP, RWRMDA and MCMDA). As it turned out, NARRMDA and the other four prediction models achieved AUCs of 0.8053, 0.6953, 0.7702, 0.7891 and 0.7718, respectively, which proved that NARRMDA has superior performance of prediction accuracy. Furthermore, we verified the prediction results associated with colon neoplasms, esophageal neoplasms, lymphoma and breast neoplasms by two different validation schemas. In these case studies, 92%, 84%, 92%, and 100% of the top 50 potential miRNAs for these four diseases were confirmed by experimental discoveries, respectively. These results further show that NARRMDA has reliable performance of prediction ability.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Molecular BioSystems
Molecular BioSystems 生物-生化与分子生物学
CiteScore
2.94
自引率
0.00%
发文量
0
审稿时长
2.6 months
期刊介绍: Molecular Omics publishes molecular level experimental and bioinformatics research in the -omics sciences, including genomics, proteomics, transcriptomics and metabolomics. We will also welcome multidisciplinary papers presenting studies combining different types of omics, or the interface of omics and other fields such as systems biology or chemical biology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信